Ultrasonographic measures of synovitis in an early phase clinical trial: a double-blind, randomised, placebo and comparator controlled phase IIa trial of GW274150 (a selective inducible nitric oxide synthase inhibitor) in rheumatoid arthritis.

Ultrasonographic measures of synovitis in an early phase clinical trial: a double-blind, randomised, placebo and comparator controlled phase IIa trial of GW274150 (a selective inducible nitric oxide synthase inhibitor) in rheumatoid arthritis.

OBJECTIVES: To test the sensitivity to change of ultrasonographic endpoints in early phase clinical trials in subjects with active rheumatoid arthritis (RA). METHODS: A double-blind, placebo and comparator controlled, randomised, two-centre study investigated the effect on synovial thickness and va...

Full description

Bibliographic Details
Main Authors:	Seymour, M, Pétavy, F, Chiesa, F, Perry, H, Lukey, P, Binks, M, Donatien, P, Freidin, A, Eckersley, R, McClinton, C, Heath, K, Prodanovic, S, Radunovic, G, Pilipovic, N, Damjanov, N, Taylor, P
Format:	Journal article
Language:	English
Published:	2012

Similar Items

Between-group differences in ultrasonographic measures of synovitis and kinetics of response to oral steroids in active RA
by: Larche, M, et al.
Published: (2006)

The effect of the potent and selective iNOS (NOS-2) inhibitor GW274150 in models of acute and establised inflammatory and neuropathic pain in the rat
by: Clayton, N, et al.
Published: (2000)

Colorectal distension-evoked iNOS, nitrotyrosine and C-FOS expression in the anaesthetised rat is inhibited by the selective iNOS inhibitor GW274150
by: Clayton, N, et al.
Published: (2001)

Quantitative power Doppler ultrasonography is a sensitive measure of metacarpophalangeal joint synovial vascularity in rheumatoid arthritis and declines significantly following a 2-week course of oral low-dose corticosteroids.
by: Larché, M, et al.
Published: (2010)

B-LYMPHOCYTE chemoattractant (BLC/CXCL13): A potential novel disease activity marker of rheumatoid arthritis
by: Pastor, I, et al.
Published: (2007)

A phase Ib/IIa clinical trial of dantrolene sodium in patients with Wolfram syndrome
by: Damien Abreu, et al.
Published: (2021-08-01)

Phase I Targeted Combination Trial of Sorafenib and GW5074 in Patients with Advanced Refractory Solid Tumors
by: Chien-Chang Kao, et al.
Published: (2022-04-01)

Results of the phase IIa RADICAL trial of the FGFR inhibitor AZD4547 in endocrine resistant breast cancer
by: R. C. Coombes, et al.
Published: (2022-06-01)

A human Phase I/IIa malaria challenge trial of a polyprotein malaria vaccine.
by: Porter, D, et al.
Published: (2011)

A human phase I/IIa malaria challenge trial of a polyprotein malaria vaccine
by: Porter, D, et al.
Published: (2011)

Phase IIa Clinical Biomarker Trial of Dietary Arginine Restriction and Aspirin in Colorectal Cancer Patients
by: Jason A. Zell, et al.
Published: (2023-03-01)

Health behaviour changes in partners of women with recent gestational diabetes: a phase IIa trial
by: Anne-Sophie Brazeau, et al.
Published: (2018-05-01)

A phase IB and randomised phase IIA trial of CApecitabine plus Radium-223 (Xofigo™) in breast cancer patients with BONe metastases: CARBON trial results
by: Matthew Winter, et al.
Published: (2022-08-01)

Is painless synovitis different from painful synovitis? A controlled, ultrasound, radiographic, clinical trial
by: Daniele Freitas Pereira, et al.

P15-01. Willingness to participate in actual preventive HIV vaccine phase I/IIa trial in Bangkok, Thailand
by: Phanuphak P, et al.
Published: (2009-10-01)

Power to identify exposure‐response relationships in phase IIa pulmonary tuberculosis trials with multi‐dimensional bacterial load modeling
by: Simon E. Koele, et al.
Published: (2024-03-01)

Evidence of blood stage efficacy with a virosomal malaria vaccine in a phase IIa clinical trial.
by: Thompson, F, et al.
Published: (2008)

Evidence of blood stage efficacy with a virosomal malaria vaccine in a phase IIa clinical trial.
by: Fiona M Thompson, et al.
Published: (2008-01-01)

Therapeutic Intervention in Multiple Sclerosis with Alpha B-Crystallin: A Randomized Controlled Phase IIa Trial.
by: Johannes M van Noort, et al.
Published: (2015-01-01)

Use of A-type CpG oligodeoxynucleotides as an adjuvant in allergen-specific immunotherapy in humans: a phase I/IIa clinical trial.
by: Senti, G, et al.
Published: (2009)

Author Correction: Results of the phase IIa RADICAL trial of the FGFR inhibitor AZD4547 in endocrine resistant breast cancer
by: R. C. Coombes, et al.
Published: (2023-01-01)

Correction: Evidence of Blood Stage Efficacy with a Virosomal Malaria Vaccine in a Phase IIa Clinical Trial
Published: (2011-01-01)

Correction: Evidence of Blood Stage Efficacy with a Virosomal Malaria Vaccine in a Phase IIa Clinical Trial.
by: Fiona M. Thompson, et al.
Published: (2011-01-01)

Transplantation of Mesenchymal Stromal Cells in Patients with Amyotrophic Lateral Sclerosis: Results of Phase I/IIa Clinical Trial
by: Eva Syková M.D., Ph.D., Dr.Sc., et al.
Published: (2017-04-01)

Comparison of ultrasonographic measures of synovitis and radiographic assessment of structural damage over two years in a randomised, controlled trial of infliximab therapy in erosive early rheumatoid arthritis.
by: Taylor, P, et al.
Published: (2004)

A phase IIa trial of the new tuberculosis vaccine, MVA85A, in HIV- and/or Mycobacterium tuberculosis-infected adults.
by: Scriba, T, et al.
Published: (2012)

STudy of Alteplase for Respiratory failure in SARS‐Cov2/COVID‐19: Study Design of the Phase IIa STARS Trial
by: Moore, Hunter B., et al.
Published: (2020)

Characterisation of SARS-CoV-2 genomic variation in response to molnupiravir treatment in the AGILE Phase IIa clinical trial
by: I’ah Donovan-Banfield, et al.
Published: (2022-11-01)

Selective Inhibition of the MK2 Pathway: Data From a Phase IIa Randomized Clinical Trial in Rheumatoid Arthritis
by: David Gordon, et al.
Published: (2023-02-01)

NGlycolylGM3/VSSP Vaccine in Metastatic Breast Cancer Patients: Results of Phase I/IIa Clinical Trial
by: Ana de la Torre, et al.
Published: (2012-09-01)

NGlycolylGM3/VSSP Vaccine in Metastatic Breast Cancer Patients: Results of Phase I/IIa Clinical Trial
by: Ana de la Torre, et al.
Published: (2012-01-01)

DON in pediatric cerebral malaria, a phase I/IIA dose-escalation safety study: study protocol for a clinical trial
by: Nginache Nampota-Nkomba, et al.
Published: (2024-01-01)

A feasibility and safety study of afamelanotide in acute stroke patients – an open label, proof of concept, phase iia clinical trial
by: Vimal Stanislaus, et al.
Published: (2023-07-01)

Safety and efficacy of low-dose intravenous arsenic trioxide in systemic lupus erythematosus: an open-label phase IIa trial (Lupsenic)
by: Mohamed Hamidou, et al.
Published: (2021-03-01)

Early vigabatrin augmenting GABA-ergic pathways in post-anoxic status epilepticus (VIGAB-STAT) phase IIa clinical trial study protocol
by: Carolina B. Maciel, et al.
Published: (2022-01-01)

RIVA – a phase IIa study of rituximab and varlilumab in relapsed or refractory B-cell malignancies: study protocol for a randomized controlled trial
by: Sean H. Lim, et al.
Published: (2018-11-01)

STROKE34 Study Protocol: A Randomized Controlled Phase IIa Trial of Intra-Arterial CD34+ Cells in Acute Ischemic Stroke
by: João Sargento-Freitas, et al.
Published: (2018-05-01)

The PACOVAR-trial: A phase I/II study of pazopanib (GW786034) and cyclophosphamide in patients with platinum-resistant recurrent, pre-treated ovarian cancer
by: Schmidt Marcus, et al.
Published: (2011-10-01)

Efficacy of the novel Plasmodium falciparum blood-stage vaccine RH5.1/AS01B in a phase I/IIA clinical trial
by: Minassian, A, et al.
Published: (2018)

Immunogenicity of a universal HIV-1 vaccine vectored by DNA, MVA and CHADV-63 in a Phase I/IIA clinical trial
by: Borthwick, N, et al.
Published: (2012)